Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miaona Liu"'
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Co-infection with Mycobacterium tuberculosis (MTB) in human immunodeficiency virus (HIV)-infected individuals is one of the leading causes of death. Also, research on HIV and MTB (HIV-MTB) co-infection was found to have a downward trend. In this work
Externí odkaz:
https://doaj.org/article/529b02e519de4c25bd7ceb9abdbb87e6
Autor:
Rongrong Zou, Ling Peng, Dan Shu, Lei Zhao, Jianfeng Lan, Guoyu Tan, Jinghan Peng, Xiangyi Yang, Miaona Liu, Chenhui Zhang, Jing Yuan, Huxiang Wang, Song Li, Hongzhou Lu, Wu Zhong, Yingxia Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The rapid worldwide spread of the Omicron variant of SARS-CoV-2 has unleashed a new wave of COVID-19 outbreaks. The efficacy of molnupiravir, an approved drug, is still unknown in patients infected with the Omicron variant.Objective: Eval
Externí odkaz:
https://doaj.org/article/83e9fa447f97470e8f1560d0fd954553
Publikováno v:
Drug discoveriestherapeutics. 16(4)
The coronavirus disease 2019 (COVID-19) pandemic continues to ravage the world, and the virus' constant evolution has made it increasingly difficult to contain. The combination of the neutralizing antibodies amubarvimab and romlusevimab has recently
Publikováno v:
Infection and Drug Resistance.
Peize Zhang,1,2 Wei Li,3 Miaona Liu,3 Senlin Zhan,2 Hailin Zhang,2 Guofang Deng,2 Xiaoyou Chen1 1Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, Peopleâs Republic of China; 2Department of Pulmonary Medicine and Tuberculosis, The Thir